Reid M. Huber, Director at Rapport Therapeutics, Inc. (RAPP), bought 20,400 shares at $24.48 ($499K) on 2025-09-12, disclosed to the SEC on 2025-09-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| INCY | SELL | 2017-05-09 | $2.0M | — | Filing → |
| INCY | SELL | 2017-03-01 | $530K | — | Filing → |
| INCY | SELL | 2017-01-11 | $2.7M | — | Filing → |